K-ras as a target for cancer therapy
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1756 (2) , 127-144
- https://doi.org/10.1016/j.bbcan.2005.08.001
Abstract
No abstract availableKeywords
This publication has 167 references indexed in Scilit:
- Trap RACK1 with Ras to mobilize Src signaling at syndecan-2/p120-GAP upon transformation with oncogenic rasBiochemical and Biophysical Research Communications, 2005
- Structural Analysis of Autoinhibition in the Ras Activator Son of SevenlessCell, 2004
- Ras GTPases: integrins' friends or foes?Nature Reviews Molecular Cell Biology, 2003
- Structural Evidence for Feedback Activation by Ras·GTP of the Ras-Specific Nucleotide Exchange Factor SOSCell, 2003
- RNA interferenceNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- RalGEF2, a Pleckstrin Homology Domain Containing Guanine Nucleotide Exchange Factor for RalPublished by Elsevier ,2000
- Suppression of Pancreatic Cancer by the Dominant NegativerasMutant, N116YJournal of Surgical Research, 1996
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994